Explore how thoughtful, well-supported transportation strategies can reduce barriers, enhance participant retention, and strengthen the overall success of clinical trials.
INSIGHTS ON CLINICAL TRIAL DESIGN
-
Understanding The FDA's Push For More Representation In Clinical Trials
Take action to improve diversity in clinical trials by addressing underrepresentation and ensuring equitable access to medical interventions, as emphasized by the FDA’s new 2025 guidance.
-
Applying AI to Study Simulation: From Design to Analysis
See how AI-generated synthetic patient populations can mirror real trial outcomes, enabling teams to test assumptions, refine protocols, and anticipate variability early — helping reduce risk, cost, and time while improving study design decisions.
-
Debunking 5 Misconceptions About Community-Based Research Sites
By confronting misconceptions about community-based research, we uncover evidence of how sites effectively manage complex trials while maintaining high standards of care.
-
What Drives Attendance And Engagement At Clinical Meetings?5/6/2026
A clear look at what drives attendance and engagement at clinical meetings, and how design decisions shape comprehension, retention, and consistency as programs scale globally over time.
-
Hey There. We're Scout4/22/2026
Learn how clear workflows, proactive support, and accessible technology help translate services into real participant retention.
-
Advantages Of Sourcing Biosimilars Vs. Branded Biologics In Clinical Trials3/12/2026
Evaluate biosimilar alternatives during clinical trial planning to reduce comparator drug costs and improve overall study efficiency without compromising trial integrity.
-
Can Your RTSM Software Vendor Handle Your Clinical Trial's Timeline Slip?3/25/2026
This clip examines why shifting study timelines expose weaknesses in rigid RTSM systems and highlights how flexible technology helps trials stay on track when plans inevitably change.
-
Health Economics And Outcomes Research (HEOR) Explained7/15/2025
Learn about this accessible way to understand what HEOR is, how it’s used, and its impact on people and healthcare systems.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Discover how to seamlessly integrate a broad range of leading industry solutions to create an innovative, patient-centered approach that caters to specific diversity and clinical trial requirements.
-
CSSi offers unmatched depth and breadth in therapeutic expertise, providing full-spectrum, in-house capabilities, positing the organization as a true end-to-end partner in clinical trials.
-
Learn how to make critical, data-driven decisions throughout the product development lifecycle and increase new therapies' probability of success.
-
Struggling with slow recruitment or fragmented sites? Explore how 35 coordinated sites and 3.5M+ patients can streamline trials from startup to close.
-
Psychiatric trials have long been among the most difficult to enroll. From treatment-resistant depression (TRD) and PTSD to cognitive and neuro disorders, sponsors are facing the same challenges over and over again:
- Narrow I/E criteria that don’t translate into real-world patients
- Sites with limited behavioral health infrastructure
- Lack of patient trust and trial awareness in psychiatric populations
- Professional patients
- Rating scales aren’t used in clinical practices
But what if recruitment didn’t have to start with a gamble?